CXCL14 and non-small cell lung carcinoma: Upregulated CXCL14 expression was also found in breast implant-associated anaplastic large cell lymphoma [38], and the over-expressed CXCL14 was associated with poor survival in non-small cell lung cancer (NSCLC) patients after curative resection [39].